COCRYSTAL PHARMA, INC. Additional Paid in Capital, Common Stock
COCRYSTAL PHARMA, INC. (COCP) had Additional Paid in Capital, Common Stock of $348.74 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $348.74M.
- 2026-03-31: Additional Paid in Capital, Common Stock $348.65M.
- 2025-12-31: Additional Paid in Capital, Common Stock $348.57M.
- 2025-09-30: Additional Paid in Capital, Common Stock $347.48M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $348.74M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $348.65M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $348.57M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $347.48M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $343.10M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $343.01M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $342.93M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $342.85M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $342.59M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $342.44M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $342.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $342.13M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $341.96M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $337.78M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $337.49M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $337.33M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $337.02M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $336.78M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $336.63M 10-K · filed 2023-03-29 | $336.54M 10-K · filed 2022-03-23 |
| 2021-09-30 | $336.32M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $336.12M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $299.63M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $297.34M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $293.52M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $277.75M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $277.63M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $260.93M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $258.13M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $258.02M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $257.91M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $253.95M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $253.68M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $253.56M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $243.71M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $243.42M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |